Optimization of Virotherapy for Cancer

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

John Nemunaitis, Fadlo R. Khuri, Ian Ganly et al. · Journal of Clinical Oncology · 2001 · 472 citations · Full text

The dynamics of an optimally controlled tumor model: A case study

L. G. de Pillis, Ami Radunskaya · Mathematical and Computer Modelling · 2003 · 398 citations

Engineering, Tumor Model, Mathematical Control Theory +7

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 386 citations

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

David Dingli, Kah-Whye Peng, Mary Harvey et al. · Blood · 2003 · 320 citations

High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus

Bambi D. Anderson, Takafumi Nakamura, Stephen J. Russell et al. · Cancer Research · 2004 · 314 citations · Full text